Health Canada approves Granules' Acetaminophen ER Tablets
Capital MarketGranules India has received marketing approval from Health Canada for Acetaminophen Extended-Release Tablets OTC, 650mg for the treatment of Arthritis Pain. The product manufactured by Granules is a bioequivalent to the reference listed drug, Tylenol Extended Release 650 Tablets.
The drug will be manufactured at the Granules manufacturing facility located in Gagillapur, Hyderabad. Granules now have a total of 2 ANDS approvals from Health Canada.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
